Gabapentin's Effects on Insomnia in Patients With Recent Concussion

State University of New York at Buffalo21 enrolled

Overview

In this open-label, pilot study the investigators will be assessing gabapentin's effects on insomnia and other concussion-related symptoms in patients with a recent concussion experiencing insomnia.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Insomnia

Interventions

GabapentinDRUG

300mg capsules by mouth

Eligibility

Sex: ALLMin age: 14 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Head trauma causing concussion with either no loss of consciousness (LOC) or LOC \< 30 minutes within previous 2 weeks. 2. ISS score at Baseline of \> 14. 3. PCSS score at Baseline \> 5. 4. If brain imaging has been checked, there was no intracerebral hemorrhage noted. 5. Glasgow Coma Scale score of 15 at Baseline. 6. Age of at least 14 years old. 7. Has not taken gabapentin or pregabalin any time since concussion and has no history of intolerance to gabapentin or pregabalin. 8. Has not taken any sleeping pills for previous 2 nights and agrees not to take any for the next 2 weeks. Exclusion Criteria:

Locations (1)

University at Buffalo, Concussion Clinic

Buffalo, New York, United States

Outcomes

Primary Outcomes

Change in Insomnia Severity Index from Baseline to 1 week

Time frame: 1 week

Secondary Outcomes

Change in Post Concussion Symptom Scale score from Baseline to 1 week

Time frame: 1 week

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.